These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 27657660)

  • 1. Discovery of novel targets for antivirals: learning from flies.
    Martins N; Imler JL; Meignin C
    Curr Opin Virol; 2016 Oct; 20():64-70. PubMed ID: 27657660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The diversity of insect antiviral immunity: insights from viruses.
    Marques JT; Imler JL
    Curr Opin Microbiol; 2016 Aug; 32():71-76. PubMed ID: 27232381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual myxovirus screen identifies a small-molecule agonist of the host antiviral response.
    Yan D; Krumm SA; Sun A; Steinhauer DA; Luo M; Moore ML; Plemper RK
    J Virol; 2013 Oct; 87(20):11076-87. PubMed ID: 23926334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening methods for influenza antiviral drug discovery.
    Atkins C; Evans CW; White EL; Noah JW
    Expert Opin Drug Discov; 2012 May; 7(5):429-38. PubMed ID: 22435452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The quest for host targets to combat dengue virus infections.
    Acosta EG; Bartenschlager R
    Curr Opin Virol; 2016 Oct; 20():47-54. PubMed ID: 27648486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights from host genomics into HIV infection and disease: Identification of host targets for drug development.
    Ballana E; Esté JA
    Antiviral Res; 2013 Nov; 100(2):473-86. PubMed ID: 24084487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dengue Virus Evolution under a Host-Targeted Antiviral.
    Plummer E; Buck MD; Sanchez M; Greenbaum JA; Turner J; Grewal R; Klose B; Sampath A; Warfield KL; Peters B; Ramstedt U; Shresta S
    J Virol; 2015 May; 89(10):5592-601. PubMed ID: 25762732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drosophila viruses and the study of antiviral host-defense.
    Huszar T; Imler JL
    Adv Virus Res; 2008; 72():227-65. PubMed ID: 19081493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Host targeted antiviral (HTA): functional inhibitor compounds of scaffold protein RACK1 inhibit herpes simplex virus proliferation.
    Ullah H; Hou W; Dakshanamurthy S; Tang Q
    Oncotarget; 2019 May; 10(35):3209-3226. PubMed ID: 31143369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Hepatitis C virus-host interaction involved in viral replication: toward the identification of antiviral targets.
    Suzuki T
    Jpn J Infect Dis; 2010 Sep; 63(5):307-11. PubMed ID: 20858994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New horizons for antiviral drug discovery from virus-host protein interaction networks.
    de Chassey B; Meyniel-Schicklin L; Aublin-Gex A; André P; Lotteau V
    Curr Opin Virol; 2012 Oct; 2(5):606-13. PubMed ID: 23025912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural biology in antiviral drug discovery.
    Bassetto M; Massarotti A; Coluccia A; Brancale A
    Curr Opin Pharmacol; 2016 Oct; 30():116-130. PubMed ID: 27611878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deconstructing host-pathogen interactions in Drosophila.
    Bier E; Guichard A
    Dis Model Mech; 2012 Jan; 5(1):48-61. PubMed ID: 21979942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolutionary conflicts between viruses and restriction factors shape immunity.
    Duggal NK; Emerman M
    Nat Rev Immunol; 2012 Oct; 12(10):687-95. PubMed ID: 22976433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quelling an innate response to dsRNA.
    Ogden KM; Prasad BV
    Oncotarget; 2015 Oct; 6(30):28535-6. PubMed ID: 26356565
    [No Abstract]   [Full Text] [Related]  

  • 16. Influenza virus-host interactomes as a basis for antiviral drug development.
    Watanabe T; Kawaoka Y
    Curr Opin Virol; 2015 Oct; 14():71-8. PubMed ID: 26364134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The future of antivirals: broad-spectrum inhibitors.
    Debing Y; Neyts J; Delang L
    Curr Opin Infect Dis; 2015 Dec; 28(6):596-602. PubMed ID: 26524332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Toll pathway is important for an antiviral response in Drosophila.
    Zambon RA; Nandakumar M; Vakharia VN; Wu LP
    Proc Natl Acad Sci U S A; 2005 May; 102(20):7257-62. PubMed ID: 15878994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting host lipid flows: Exploring new antiviral and antibiotic strategies.
    Fernández-Oliva A; Ortega-González P; Risco C
    Cell Microbiol; 2019 Mar; 21(3):e12996. PubMed ID: 30585688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Host-pathogen interactions in drosophila: new tricks from an old friend.
    Cherry S; Silverman N
    Nat Immunol; 2006 Sep; 7(9):911-7. PubMed ID: 16924255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.